Account
Blue Buzz bags Enrission India’s PR mandate
Mumbai: Enrission India, a leading platform committed to empowering Indian startups, in collaboration with Enrission India Capital Inc. which is an India-focused VC firm based in Japan, has announced the appointment of Blue Buzz as its official PR agency in India. This collaboration aims to bolster Enrission India’s communication and outreach strategy, building a robust brand presence in the rapidly evolving startup ecosystem.
Enrission India principal Harsh Deodhar expressed his enthusiasm for this partnership, stating, “Blue Buzz comes with a nuanced marketing approach specifically tailored for startups. Their bespoke strategies are designed to address real-time brand needs, while also helping to build a strong foundation for the future.”
Blue Buzz founder and CEO Neha K Bisht added, “It’s great to partner with a company that is focused on supporting Indian startups and providing them with the tools they need to grow and succeed. We are dedicated to helping Enrission India Capital establish a solid brand identity in the market, while fostering a valuable exchange for learning and development.”
The partnership between Enrission India and Blue Buzz is expected to drive Enrission’s mission forward, positioning it as a leading name in the Indian startup ecosystem. The focus will be on strategic communication to elevate Enrission India’s brand narrative and enhance its outreach.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
